<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/smartmatic-fcpa-indictment-dismissal/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T22:19:55.000Z</news:publication_date>
      <news:title>Smartmatic Fights First Corporate FCPA Indictment Since 2010</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pancreatic-cancer-herceptin-1998-turning-point/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T18:29:27.000Z</news:publication_date>
      <news:title>Compared to Herceptin&apos;s 1998 Approval: Pancreatic Cancer Hits a Turning Point</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/novartis-abelacimab-cuts-cancer-trials/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T17:25:29.000Z</news:publication_date>
      <news:title>Cut 2 Abelacimab Cancer Trials, Novartis Bets $925M on Afib</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/apollo-mckesson-mms-minority-stake/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T16:28:50.000Z</news:publication_date>
      <news:title>Paid $1.25B, Apollo Takes 13% of McKesson&apos;s Surgical Unit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/kyverna-miv-cel-sps-car-t-fda/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T15:33:19.000Z</news:publication_date>
      <news:title>Kyverna Sweeps All KYSA-8 Endpoints: 46% SPS Improvement, FDA Filing Next</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/gilead-arcus-domvanalimab-tigit-exit/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T14:38:41.000Z</news:publication_date>
      <news:title>Gilead Cuts Arcus TIGIT Option After Domvanalimab&apos;s 2 Trial Failures</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-7b-gene-therapy/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T13:54:45.738Z</news:publication_date>
      <news:title>Lilly Paid $7B for Kelonia&apos;s Gene Therapy Delivery Platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/utah-clinical-ai-sandbox/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T13:37:35.000Z</news:publication_date>
      <news:title>Utah Built the Clinical AI Sandbox Founders Are Racing Toward</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/esma-mica-eu-crypto-exit/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T12:29:18.000Z</news:publication_date>
      <news:title>ESMA Orders Unlicensed Crypto Firms Out of EU Markets by July 1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/merck-keytruda-triplet-fails-rcc/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T03:10:49.000Z</news:publication_date>
      <news:title>Paid $5.76B: Merck&apos;s Keytruda Triplet Fails Both RCC Endpoints</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/adobe-cx-enterprise-outcome-pricing/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:56:00.000Z</news:publication_date>
      <news:title>Adobe Ditches Token Pricing for AI, Charges by Outcome Now</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/chrome-gemini-ai-3b-users-agentic/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:54:00.000Z</news:publication_date>
      <news:title>Google Wires Gemini AI Into Chrome&apos;s 3 Billion Users Overnight</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lloyds-sameer-gupta-ai-chief-dbs/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:52:00.000Z</news:publication_date>
      <news:title>Lloyds Picks DBS&apos;s Sameer Gupta as First Chief AI Officer, June Start</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/unitedhealth-15b-ai-2x-return/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:50:00.000Z</news:publication_date>
      <news:title>UnitedHealth Pours $1.5B Into AI, Expects $3B Back in 18 Months</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/utah-doctronic-ai-prescription-refills/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:44:47.407Z</news:publication_date>
      <news:title>Utah Cleared Doctronic for AI Prescription Refills. Who&apos;s Next?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/coinbase-gemini-new-york-gambling-suit/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:42:44.074Z</news:publication_date>
      <news:title>Sued Over Prediction Markets, Coinbase and Gemini Push Back</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/pace-act-occ-nonbank-fintechs/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:40:43.398Z</news:publication_date>
      <news:title>PACE Act Cuts 40-State License Requirement for Payment Fintechs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/roche-fenebrutinib-death-imbalance-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:40:01.321Z</news:publication_date>
      <news:title>Cleared Phase 3 Twice, Roche&apos;s Fenebrutinib Carries an 8-to-1 Death Imbalance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/replimune-cuts-224-fda-rp1/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:39:42.272Z</news:publication_date>
      <news:title>Replimune cuts 224 jobs after FDA&apos;s second RP1 rejection</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/nc-biotech-cell-gene-symposium-unc/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:10:00.000Z</news:publication_date>
      <news:title>NC Biotech Gathers CAR-T Crowd at UNC Friday After $7B Kelonia Deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/roche-ms-pill-aubagio-liver/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T02:02:19.359Z</news:publication_date>
      <news:title>Doubles Relapse-Free Interval: Roche&apos;s MS Pill Beats Aubagio, Flags Liver Risk</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/jetblue-congress-ai-surveillance-pricing/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T01:53:50.765Z</news:publication_date>
      <news:title>Questioned by 2 Lawmakers, JetBlue Faces AI Pricing Probe</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/carvykti-smoldering-myeloma-dana-farber/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T01:39:09.000Z</news:publication_date>
      <news:title>Carvykti shows promise in all 20 smoldering myeloma patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/merck-welireg-fails-first-line-kidney/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-22T00:42:37.000Z</news:publication_date>
      <news:title>Failed: Merck&apos;s Welireg Combo in First-Line Kidney Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/amazon-price-fixing-california-ag/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T23:17:08.000Z</news:publication_date>
      <news:title>Sued for Price-Fixing, Amazon Faces California AG at July 23 Hearing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/key-tronic-sec-books-records-penalty/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T22:18:49.000Z</news:publication_date>
      <news:title>Ordered to Pay $35K, Key Tronic Executives Doctored Inventory Records</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/florida-openai-chatgpt-shooting-probe/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T21:31:27.379Z</news:publication_date>
      <news:title>Grilled by Florida Over Mass Shooting, OpenAI Defends ChatGPT</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/novartis-cuts-two-cancer-clot-programs/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T18:29:06.000Z</news:publication_date>
      <news:title>Novartis Cuts 2 Late-Stage Programs on Inferior Efficacy Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/trump-eo-psychedelics-cnpv-review/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T17:26:36.000Z</news:publication_date>
      <news:title>Signed April 18: Trump EO Cuts Psychedelic Reviews to 1-2 Months</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-7b-car-t/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T16:29:45.000Z</news:publication_date>
      <news:title>Lilly Paid $3.25B Upfront for Kelonia in $7B CAR-T Deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/gilead-cuts-arcus-domvanalimab-phase-3/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T15:34:05.000Z</news:publication_date>
      <news:title>Gilead Cuts Arcus Ties After Domvanalimab Phase 3 Failure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/trump-eo-psychedelics-compass-2027/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T14:40:14.000Z</news:publication_date>
      <news:title>Trump EO Cuts Psychedelic Review to 2 Months, Sends Compass Up 25%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-7b-lentiviral/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T13:51:13.693Z</news:publication_date>
      <news:title>Lilly Paid $7B for Kelonia&apos;s Lentiviral In Vivo Platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/cbp-ieepa-refund-portal-166b/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T12:30:24.000Z</news:publication_date>
      <news:title>CBP Opens $166B IEEPA Refund Portal, Full Payout Still Uncertain</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/west-coast-chatbot-trio-ca-or-wa/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T11:30:00.000Z</news:publication_date>
      <news:title>West Coast Chatbot Laws: California Live, Oregon and Washington Queue Up for 2027</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/texas-traiga-110-days-enforcement-posture/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T11:00:00.000Z</news:publication_date>
      <news:title>Texas TRAIGA at 110 Days — What the 60-Day Cure Period Actually Buys You</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/mobley-workday-hiredscore-ai-hiring-class/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T10:30:00.000Z</news:publication_date>
      <news:title>Mobley v. Workday Expanded to HiredScore Users — The AI-Hiring Class Widens</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/ftc-rytr-order-set-aside-ai-comply-retreat/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T10:00:00.000Z</news:publication_date>
      <news:title>FTC Set Aside Its Rytr AI Order — Operation AI Comply Is Selectively Retreating</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/colorado-ai-act-june-2026-10-weeks/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T09:30:00.000Z</news:publication_date>
      <news:title>Colorado AI Act Goes Live in 10 Weeks — What High-Risk Deployers Owe June 30</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/sec-nate-saniger-42m-ai-washing/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T09:00:00.000Z</news:publication_date>
      <news:title>SEC Charged Nate Founder $42M for AI-Washing — What Founders Learn a Year Later</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/cbp-ieepa-tariff-refunds-walmart/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T03:10:50.000Z</news:publication_date>
      <news:title>Opened: CBP&apos;s $127B Tariff Refund Portal; Walmart Owed $10.2B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/zaglin-drops-new-trial-motion/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T02:47:40.960Z</news:publication_date>
      <news:title>Zaglin Drops New Trial Motion, 8-Year FCPA Sentence Stands</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/trump-eo-psychedelic-compass-review/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T00:45:17.000Z</news:publication_date>
      <news:title>Trump EO Cuts Psychedelic Reviews, Compass Jumps 25%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-7b-igps-platform/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T23:19:52.000Z</news:publication_date>
      <news:title>Lilly Cuts $7B Deal for Kelonia and Its iGPS Platform</news:title>
    </news:news>
  </url>
</urlset>